The crystalline lens is an avascular transparent organ and under normal physiological conditions embedded in a low oxygen environment. During hyperbaric oxygen (HBO) therapy in a monoplace chamber, the patient is surrounded by pure oxygen at a pressure higher than atmospheric. The monoplace chamber compresses one patient at a time, placed in a supine position. Breathing oxygen at high pressure increases the transfer of oxygen from blood to tissue in an attempt to revitalize oxygen-dependent metabolism in ischemic body tissue. HBO therapy is a commonly used medical treatment in a variety of human diseases, including radiationinduced osteonecrosis, proctitis and cystitis following previous cancer therapy.
A temporary myopic shift has often been described in patients treated with HBO therapy. [1] [2] [3] [4] [5] [6] In a previous article, we reported that the myopic shift was caused by changes in the crystalline lens because the refractive changes appeared only in phakic and not in pseudophakic eyes. 5 Changes in other optical refractive elements of the eye did not explain the degree of the myopic shift. [4] [5] [6] The myopic shift appears to be fully reversible within 10 weeks after completion of the treatment. 6 To achieve high quality of vision, the crystalline lens must allow for the unimpeded passage of light and provide sufficient refractive power to focus a sharp image on the retina. The refractive index is determined by the concentration of lens proteins, 7 the composition and distribution of which influence the amount of light scatter, absorption and transmission through the lens tissue.
Formation of nuclear cataract has been observed in a patient after a standard course of therapeutic HBO, 8 and oxidative stress causing damage to lens components is proposed to play an important role. 9 Development of nuclear cataract is reported after extended periods of HBO exposure in patients with initially clear lenses before the start of treatment. 10 The visual side effect of HBO therapy is reported to be a cumulative process, 5, 11 and each daily treatment session is of equal oxygen load and duration. Changes in lenticular transparency may therefore take place long before any changes of the lens are clinically detectable by slitlamp examinations. 11 Any explanation of the mechanism causing the refractive changes must also take into account that both significant myopic shifts [1] [2] [3] [4] [5] [6] and hypermetropic shifts 12, 13 may occur in patients treated with HBO therapy.
The present study was undertaken to examine lens surface curvatures, axial thickness and structural changes in order to elucidate the mechanisms underlying the myopic shift and cataractrelated changes that occur in some patients during hyperbaric oxygen therapy. Ocular refraction, central corneal radius, intraocular pressure, anterior chamber depth and axial length of the eye were additionally monitored to verify if these variables were consistent with previously reported values.
MATERIALS AND METHODS
Patients referred to Haukeland University Hospital for elective HBO therapy were invited to take part in the study as they presented for the treatment. Twenty patients (10 males and 10 females) with a mean age of 56.0  7.7 years, (age range 44 to 68 years) met the inclusion criteria, and attended the daily scheduled HBO sessions without interruptions. All had treatment for radiationinduced osteonecrosis, proctitis or cystitis. All the patients were of Caucasian origin.
The protocol was approved by the Regional Ethics Committee and the Norwegian Data
Inspectorate. Eye examinations were performed with the full understanding and written consent of each patient, according to the tenets of the Declaration of Helsinki for research involving human subjects. Inclusion criteria were age below 70 years, normal ocular health and a spectacle prescription within  5.00 D. None of the patients had visual complaints or any subjective reduction in visual acuity. Those with HBO therapy during the past 12 months, radiotherapy of the orbit, corneal refractive surgery or any wearing of contact lenses were excluded to avoid effects on corneal curvature. All measurements were conducted by the same investigator (KE) to avoid inter-examiner bias.
HBO therapy was given once daily for 20 days, five days a week in accordance with the standard protocol. 5 The patients were compressed with oxygen in a monoplace hyperbaric chamber to a total pressure of 240 kPa over a period of 10-15 minutes. 100% oxygen was breathed at this pressure for 90 minutes, in three cycles of 30 minutes, interrupted by breathing compressed air from an oronasal mask for five minutes between the cycles. After each treatment session, the patients were decompressed to normal atmospheric pressure in 7-10 minutes.
The eye examination consisted of objective refraction, keratometry, measurements of forward scattered light, intraocular pressure, axial length of the eye, Scheimpflug pictures (lens optical density, lens surface curvatures, anterior chamber depth, axial lens thickness, pupil diameter), and backward scattered light. A routine eye examination with the slitlamp biomicroscopy and ophthalmoscopy was also undertaken. Patients arrived to the hospital late in the afternoon the day before, or in the morning on the day they started the HBO therapy. There was no time to perform the eye examination before the patients entered the chamber on the first day of treatment. For this reason baseline measurements were performed in the afternoon after completion of the first session of HBO therapy (day 1). Follow-up measurements were repeated in identical sequences within the same hour of the day when the patients had completed 19 days of the regular treatment.
Objective refraction and keratometry were assessed with the Nidek ARK 900 autorefractor/keratometer (Nidek Co., Ltd., Gamagori, Japan). Refractive changes measured with this instrument through an undilated pupil have previously shown high correlations both between the right and left eye and with subjective refraction 5 . Hence, in the present study, the subsequent measurements and data comparisons were taken from the right eye only.
Forward scattered light was measured with the C-Quant straylight meter (Oculus Optikergeräte, Germany), which is based on the compensation comparison method. [14] [15] [16] The patient focuses with one eye on the circular test field, which is divided into a right and a left semicircle.
Compensating light is randomly presented in one of the two semicircles. A number of short stimuli are presented during the test, and the patient activates the corresponding right or left push button depending on which of the two semicircles flickers more intensely. A logarithmic straylight parameter value (log s, base 10) is established for the C-Quant, and determines the ratio between the scattered light and the non-scattered light. With log s notation, the straylight value changes linearly. Equal differences in log s correspond to equal differences in s ratio, and an increase of 0.3 correlates with a doubling of the amount of straylight. An average logs value for young healthy eyes is around 0.9.
Deviation (ESD)  0.08 were used as limits for reliable measurements. 14 An ICare Rebound tonometer (Tiolat Oy, Helsinki, Finland) was applied to monitor intraocular pressure. 17 All the above-mentioned examinations were performed through undilated pupils. Due to logistical considerations and in order to reduce patients waiting time, mydriatic eye drops were administered before the patients moved to complete the measurements in another laboratory. The final examinations included Scheimpflug imaging, which require a wide open pupil. A minimum 4 mm diameter pupil is required for backward scattered light assessment. 18 Axial length of the eye was measured before the Scheimpflug imaging as the instrument was located in the same room and can be used both with and without pupil dilatation. Table 1 Lens surface radius was examined in the "Axial Biometry" program by placing the cursor on three intersecting points along the curvature of the anterior surface and the posterior surface of the lens ( Figure 1B ). Anterior chamber depth was examined by placing the cursor along the optical axis, and displayed as the distance between the intersection points at the posterior cornea and anterior apex of the lens (one pixel equals about 0.026 mm). 21 Axial thickness of the lens was measured along the optical axis ( Figure 1C ). The pupil diameter was measured as the largest vertical edge-to-edge distance, in order to verify size of the pupil during dilatation. Here F is the power of the lens surface, and r is the absolute value of the radius. These parameters were implemented into the customary thick lens formula:
in which LP is the equivalent lens power, F1 and F2 are the anterior and posterior lens surface powers, t is the lens thickness (in metres), and n is the refractive index of the lens (1.416).
Statistics
The objective refractive state values were converted into spherical equivalent refraction (sphere 
RESULTS

Refractive Changes
A significant mean myopic shift occurred for the full sample of 20 patients during treatment, For the six patients for whom the posterior lens surface data were available (Table 2) 
Forward Scattered Light
Forward scattered light showed no significant changes from before to after HBO therapy, 0.02  0.15 log s units.
Ocular Biometry
No significant differences in mean central corneal radius (-0.01  0.03 mm), intraocular pressure (-0.7  1.8 mmHg), axial length of the eye (0.00  0.02 mm) and anterior chamber depth (0.01  0.02 mm) were measured.
Lens Optical Density
There was a decrease in lens optical density after HBO therapy compared to before therapy. The nucleus showed a significant reduction in mean optical density after treatment of 2. (Table 2) . Changes in mean optical density within the anterior and posterior cortical areas, and peak density in the central subcapsular region were not statistically significant.
Lens Curvatures and Thickness
There were no significant differences in the anterior lens surface radius (-0.01  0. (Table 3) .
Backward Scattered Light
A small but statistically significant reduction was found in mean backscattered light after HBO therapy compared to before the therapy, 0.4  0.8 units (range 2.0 units to 1.0 units) (p = 0.022). The age-related trends showing an increase with age in backscattered light and nuclear optical density at the baseline visit were not changed after the treatment (Figure 2 ).
DISCUSSION
A significant myopic shift (-0.50 D) occurred in 13 (65%) single eyes during the study period.
After three weeks of the treatment, most of the patients noticed a change in visual quality with their current correction. The best-corrected visual acuity appears to be stable during a standard course of HBO therapy. To explain the increase in refractive power as resulting from an increase in nuclear refractive index would appear to be inconsistent with the decline in nuclear optical density following treatment that was found in this study. The explanation for this apparent contradiction is most likely to come from the fact that the lens has a gradient of refractive index in the cortical region with a relatively constant refractive index in the nucleus. 25, 26 Rays of light are refracted when they encounter a change in refractive index; the greater the change or the steeper the gradient of index, the greater is the refractive power. In a gradient index lens 25 structure, a relatively subtle change in the shape of the refractive index gradient will alter the equivalent refractive index of the lens. If the measured decrease in nuclear optical density does indeed indicate a decrease in nuclear refractive index, an explanation for a greater refractive power could be a steepening of the gradient index in the cortex 25 and would require only subtle changes in local magnitude of refractive index. No significant differences were found in the cortical density after treatment, but the measure was averaged across a substantial cortical region and hence masked any local variations.
The gradient refractive index of the lens is formed by the concentration and distribution of its structural proteins: the crystallins, which constitute just over a third of the wet weight of the human lens. 27 Local changes in refractive index occur when the protein concentration change in that region. Since water in the lens exists as either, free water or water bound to proteins, a change in local protein concentration can also be related to an increase in the proportion of free water as bound water is released. 28 The results show a significant decline in lens optical density and backscatter, which can be related to a localised change in water state. Since lens proteins are not considered to be independent scatterers, 29 it may be that the decrease in backscatter is caused by a tighter packing of proteins, [30] [31] [32] which is not incompatible with a release of bound water.
During HBO therapy, the lens equator is exposed to an enhanced concentration of blood-born oxygen, which passes the blood-aqueous barrier. HBO exposure to bovine lenses in organ culture has been shown to cause reversible optical changes, which progress from the periphery of the lens to its centre causing a change in focal length. 11 These results support the suggestion that HBO treatment causes changes in the cortical gradient. Changes in cortical refractive index gradient could also explain the occurrence of hypermetropic shifts that have been reported in patients after HBO therapy. 12, 13 Despite a few exceptional cases that have reported cataract formation in human eyes following HBO therapy, 8, 10 the myopic shifts tend to attenuate and disappear some weeks after completion of the treatment. 6 Two patients in the study of Palmquist et al. were observed with a partly reversible nuclear cataract.
myopic shift, the time course of the myopic shift and its reversal need to be taken into account when considering the underlying mechanism.
The Lens Opacity Meter measures diffuse changes in backward scattered light from a projected cylindrical light beam in the axial part of the lens. 18 Adjusted for dilated pupils and age, the degree of overall lenticular opacification was within the defined limits of clear lenses 18 for all the patients during HBO therapy ( Figure 2 ). As the assessment was conducted through a dilated pupil with a minimum diameter of 6.00 mm, any absorption by the iris 33 would be negligible.
The minimum pupil diameter appeared slightly larger after the therapy (Table 3) . But larger pupils would rather release more backscattered light, 18 while a reduction in scattered light occurred. Backward scattered light from a slit beam (as observed through the biomicroscope slitlamp), collect changes from a wider sectional area of the lens and are more susceptible to the location and origin of the lens changes. 18 No lenses were seen with distinct cortical spoke opacities, which could artificially interfere with back projected shadows and thus affect the measurements. Hence, the small but significant decrease in backscattered light from the lens after HBO therapy could be influenced by reduced fluctuations in the gradient of the refractive index 25 or by destructive interference. 31 Under normal physiological conditions, a myopic shift (1.00 D) occurring over four years in the adult human eye might be the first sign of underlying cataract. 34 When the lens subsequently manifests with increased turbidity and reduced transparency, structural changes may already have been underway for some time. Lenticular changes in refraction may take place long before any loss of lens transparency can be seen on gross observation in the lens.
therefore be an early latency period during HBO therapy, in which scatter is reduced because of reorganisation of the crystalline proteins and a change in water content, before this manifests as localised aggregations of protein and formation of cataract. Most measuring devices in the normal eye care clinic are unlikely to be sufficiently sensitive to detect the variations in lenticular optical properties during the very first phase of these changes.
Improved oxygen supply to ocular ischemic tissue may reduce swelling and volume associated with low oxygen tension. Resolution of macula oedema and reduced retinal thickness has been reported in a diabetic patient during HBO therapy. 35 No changes in intraocular pressure or axial length of the eye occurred in these patients after treatment, which is in line with results reported in other studies using the similar HBO treatment protocol. 4, 5, 12 A limitation of the study is that posterior surface of the lens appeared visible only in one third of the patients because of restricted dilation of the pupil. Large pupils are determined by the contraction of the dilator pupillae muscles and the relaxation of the sphincter pupillae muscles, which are innervated by the sympathetic and parasympathetic nervous system, respectively.
Hyperbaric oxygen inhalation has shown to increase parasympathetic activity in professional divers, and might thus be a contributing factor to the limited mydriasis. 36 In addition, senile miosis is a well-known phenomenon 37 with decrease in pupil area in later adulthood among normal subjects. All the patients in this study had reached the age of presbyopia.
In conclusion, the present study shows that the only measurable ocular change accompanying the temporary myopic shift in patients undergoing HBO therapy is a significant reduction in backscattered light and optical density of the lens. These findings indicate that the myopic shift is most likely caused by changes in the structure of the lens tissue, leading to subtle alterations in the refractive index gradient. 
